TAG:
pathology practice
Pathology Consolidation Underway in Washington
By R. Lewis Dark | From the Volume XXI No. 7 – May 19, 2014 Issue
CEO SUMMARY: Two regional pathology super-practices have emerged in Washington State. In each case, acquisitions and mergers are fueling the growth of the two large pathology groups. In Western Washington and the Seattle metro, CellNetix is the dominant pathology group, with 53 physicians…
Pathology Groups Respond to Eroding Finances
By R. Lewis Dark | From the Volume XXI No. 4 – March 17, 2014 Issue
THESE ARE NOT THE BEST OF TIMES FOR ANATOMIC PATHOLOGY GROUPS. The various Medicare fee cuts enacted in the past couple of years have eroded the financial stability of a substantial number of the nation’s 3,300 independent pathology practices and laboratories. The consequences of eroding finances …
Anatomic Pathology Business Faces Uncertain Future
By Robert Michel | From the Volume XXI No. 4 – March 17, 2014 Issue
CEO SUMMARY: There’s a day of reckoning on the way for the traditional business model of the private pathology group practice. At most risk are smaller pathology groups that typically have five or fewer pathologists. Blame it on the reduced prices that Medicare and private insurers are …
Medicare Price Cuts Drive Labs to Sell or File BK
By Robert Michel | From the Volume XX No. 15 – November 11, 2013 Issue
CEO SUMMARY: Professional investors are smart with their money. Thus, it is no surprise that clinical lab and pathology companies owned by private equity firms are the first to be sold or closed. These investors are acting in response to the cumulative negative financial impact of recent …
Ottawa Pathology Lab Cuts Turnaround Time By More Than 50%
By Joseph Burns | From the Volume XX No.14 – October 21, 2013 Issue
CEO Summary: Pathologists at Ottawa Hospital not only must handle a large volume of specimens regularly, but are experiencing a 14% per year growth in the number of specimens. Last year, when the average turnaround time for a case was nine days, the pathology department embarked …
Coming Soon to Your City: More Hospital Mergers
By R. Lewis Dark | From the Volume XX No.14 – October 21, 2013 Issue
UPON THE COMPLETION OF THEIR MERGER AT THE END OF SEPTEMBER, Baylor Health Care System and Scott & White Healthcare became the largest not-for-profit health system in Texas, boasting $8 billion in assets and annual revenue of about $6 billion. Now known as …
Attorneys for CAP Say CMS Fee Proposals Illegal
By Joseph Burns | From the Volume XX No. 12 – September 9, 2013 Issue
CEO SUMMARY: In its comments about a proposal to change the way CMS pays for clinical laboratory and pathology services, the College of American Pathologists (CAP) said that CMS is using faulty assumptions. CAP further commented that the CMS proposal to cap physician fee schedule payments…
Labs Push to Cut Costs As Budgets, Prices Shrink
By Robert Michel | From the Volume XX No. 11 – August 13, 2013 Issue
CEO SUMMARY: Cost-cutting is now the prime directive at progressive labs because nearly every laboratory organization in the United States is under sustained financial pressure. This is due to shrinking budgets for hospital labs and more aggressive price-cutting by private payers. Even Ob…
PathCentral Launches Sale of New Anatomic Pathology LIS
By Joseph Burns | From the Volume XX No. 9 – July 8, 2013 Issue
THERE IS A NEW PLAYER in the market for anatomic pathology laboratory information systems (APLIS). This gives pathology groups a new option when it is time to upgrade or replace their existing APLIS. It also brings a new competitor into the existing market for anatomic pathology (AP) software. In re…
Payers Bolix MDx Codes, Labs Unpaid for Months
By Joseph Burns | From the Volume XX No. 5 – April 15, 2013 Issue
CEO SUMMARY: Clinical laboratories complain that implementation of a new payment system for molecular tests has been a disaster since January 1. Most contractors for the federal Centers for Medicare & Medicaid Services have not paid labs for molecular tests billed thi…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized